title: Selecting the Duration of Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Complex Decision or Not?
authors.affiliation: Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.
authors.forename: Robert C
authors.initials: RC
authors.lastname: Welsh
authors.affiliation: Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina. Electronic address: peter016@mc.duke.edu.
authors.forename: Eric D
authors.initials: ED
authors.lastname: Peterson
mesh_terms: D001241:Aspirin; D004359:Drug Therapy, Combination; D054855:Drug-Eluting Stents; D062645:Percutaneous Coronary Intervention; D010975:Platelet Aggregation Inhibitors; D015607:Stents; D013988:Ticlopidine
chemical_list: D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine; D001241:Aspirin
keywords: angioplasty; antiplatelet therapy; stents